Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 8 min 28 sec ago

Cohera Medical, Inc.(R) Receives PMA Approvable Letter from U.S. FDA for TissuGlu(R) Surgical Adhesive

Tue, 01/06/2015 - 12:53
Cohera CEO to present on latest Company updates at 33rd Annual J.P. Morgan Healthcare Conference PITTSBURGH, Jan. 6, 2015 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical a...
Devices, FDA
Cohera Medical, surgical adhesive, TissuGlu

CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)

Tue, 01/06/2015 - 12:46
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients Novel Albumin-Binding Drug Candidate Appears to Allow Doxorubicin to Cross the Tumor's Blood-Brain Barrier in Humans LOS ANGELE...
Biopharmaceuticals, Oncology
CytRx, aldoxorubicin, glioblastoma multiforme, brain cancer

Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer

Mon, 01/05/2015 - 23:56
CORAL GABLES, Fla., Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceutical Partners, Inc. (Catalyst Pharmaceuticals) (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people wi...
Biopharmaceuticals, Personnel
Catalyst Pharmaceutical, Firdapse

GlySens Incorporated Secures $12M Series C Investment

Mon, 01/05/2015 - 23:51
Proceeds dedicated to advanced product commercialization steps SAN DIEGO, Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- GlySens Incorporated announced today that it has closed a $12 million dollar Series C investment round, which included p...
Devices, Endocrinology, Venture Capital
GlySens, continuous glucose monitoring system

Aduro Biotech Closes $51.4 Million Series D Financing

Mon, 01/05/2015 - 13:12
Investment for Expansion of Research and Clinical Development of Aduro’s Immuno-Oncology Technology Platforms BERKELEY, Calif.--(Healthcare Sales & Marketing Network)--Aduro Biotech, Inc., a clinical-stage immuno-oncology company, today announced the cl...
Biopharmaceuticals, Oncology, Venture Capital
Aduro Biotech

Stereotaxis Receives FDA Clearance of Vdrive(R) With V-CAS(TM) System Along With Regulatory Approval of Odyssey(R) System in Japan

Mon, 01/05/2015 - 13:05
ST. LOUIS, Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) for its Vdrive(R) with V-CAS(TM) Catheter Advancement System in th...
Devices, Cardiology, Regulatory
Stereotaxis, Vdrive , V-CAS , Catheter Advancement System

CardioFocus partners with Japan Lifeline for distribution of the HeartLight Laser Balloon to treat Atrial Fibrillation

Mon, 01/05/2015 - 12:58
Massachusetts company taps Japan EP market leader to introduce proprietary technology MARLBOROUGH, Mass., Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the t...
Devices, Cardiology, Distribution
CardioFocus, Japan Lifeline Co, HeartLight, Endoscopic Ablation

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong